期刊文献+

肝脾论治辅助治疗甲状腺相关性眼病56例 被引量:1

下载PDF
导出
摘要 目的:探讨肝脾论治辅助西医治疗甲状腺相关性眼病的临床疗效。方法:将56例确诊甲状腺相关眼病患者随机分为两组,A组在正规的西药治疗方案基础上予以中药汤剂辩证施治(中药+强的松),B组采用正规的西药治疗(强的松)方案;疗程12 w,观察两组患者眼痛、眼胀、流泪、复视、突眼度的变化。结果:A组眼痛、眼胀、流泪、复视、突眼度有效率分别为90.0%、96.3%、96.2%、89.3%、85.7%,B组对应症状的有效率为58.3%、60.7%、59.3%、59.3%、53.6%;两组间比较有显著性差异(P<0.05或P<0.01)。结论:通过肝脾论治,采用中药汤剂辩证施治辅助甲状腺相关眼病可以取得良好的疗效。
出处 《中药材》 CAS CSCD 北大核心 2009年第9期1493-1494,共2页 Journal of Chinese Medicinal Materials
  • 相关文献

参考文献6

  • 1Bartalena L, Pinchera A, Marcocci C. Management of Grave' ophthalmopathy:reality and perspectives [ J]. Endocrine Reviews, 2000,21 (2) : 168-199.
  • 2孙华(综述),赵咏桔(审校).甲状腺相关眼病活动性评判及病情的影响因素[J].国外医学(内分泌学分册),2005,25(1):39-41. 被引量:12
  • 3Igarashi H, Medina KL, Yokota T, et al. Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids [ J ]. Int Immunol, 2005,17 (5) :501-511.
  • 4潘善余.内分泌性突眼的病因病机及治疗浅探[J].浙江中西医结合杂志,2004,14(7):425-426. 被引量:4
  • 5郭立忠主编.现代实用中药学[M].北京:人民卫生出版社,1999:167.
  • 6熊曼琪,邓兆智.内分泌科专病与风湿病中医临床诊治[M].北京:人民卫生出版社,2002:60-65

二级参考文献17

  • 1Durak H, Soylev M, Durak I, et al. Tc-99m polyclonal human immunoglobulin G imaging in Graves' ophthalmopathy. Clin Nucl Med,2000,25: 704-707.
  • 2Ortapamuk H, Hosal B, Naldoken S. The role of Tc-99m polyclonal human immunoglobulin G scintigraphy in Graves' ophthalmopathy. Ann Nucl Med, 2002,16:461-465.
  • 3Kulig G, Pilarska K, Kulig J, et al. Usefulness of soluble ICAM-1 measurements for the evaluation of the disease activity and efficiency of therapy in patients with infiltrative Graves' ophthalmopathy. Pol Arch Med Wewn,2002,108:1161-1169.
  • 4De Bellis A, Di Martino S, Fiordelisi F, et al. Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy. J Clin Endocrinol Metab, 1998,83:1222-1225.
  • 5Mysliwiec J, Kretowski A, Szelachowska M, et al. Serum L-selectin and ICAM-1 in patients with Graves' ophthalmopathy during treatment with corticosteroids. Immunol Lett, 2001,78:123-126.
  • 6Gunji K, De Bellis A, Li AW, et al. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism. J Clin Endocrinol Metab, 2000, 85: 1641-1647.
  • 7De Bellis A, Bizzarro A, Conte M, et al. Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy. Clin Endocrinol ( Oxf),2003,59: 388-395.
  • 8Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med, 1998,338: 73-78.
  • 9Marcocci C, Bruno-Bossio G, Manetti L, et al. The course of Graves'ophthalmopathy is not influenced by near total thyroidectomy: a casecontrol study. Clin Endocrinol (Oxf), 1999,51: 503 -508.
  • 10Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspective. Endocr Rev, 2000,21:168-199.

共引文献15

同被引文献31

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部